AWM Investment Company’s PureTech Health PRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,900
Closed -$197K 105
2024
Q1
$197K Buy
+6,900
New +$176K 0.03% 112
2023
Q4
Sell
-70,000
Closed -$1.61M 115
2023
Q3
$1.61M Hold
70,000
0.24% 73
2023
Q2
$2.12M Hold
70,000
0.29% 67
2023
Q1
$2.03M Sell
70,000
-1,300,000
-95% -$38.5M 0.27% 73
2022
Q4
$6.42M Buy
1,370,000
+1,300,000
+1,857% +$38.7M 0.93% 36
2022
Q3
$1.89M Sell
70,000
-590,000
-89% -$15.6M 0.29% 72
2022
Q2
$2.51M Buy
660,000
+630,000
+2,100% +$14.5M 0.4% 61
2022
Q1
$758K Hold
30,000
0.1% 105
2021
Q4
$1.11M Hold
30,000
0.11% 106
2021
Q3
$1.44M Hold
30,000
0.14% 101
2021
Q2
$1.47M Hold
30,000
0.15% 108
2021
Q1
$1.77M Hold
30,000
0.2% 88
2020
Q4
$1.67M Buy
+30,000
New +$1.33M 0.21% 79

Other funds holding PRTC

AWM Investment Company's PRTC Position: Q2 2024 in Review

AWM Investment Company sold out of PureTech Health (PRTC) in Q2 2024, closing a stake of 6,900 shares — an estimated $197K sold.

AWM Investment Company first reported a position in PRTC in Q4 2020 and held it in 13 quarters. The position peaked at $6.42M in Q4 2022. 6 funds tracked by Wall St. Rank hold PRTC as of Q2 2024.

  • AWM Investment Company reported no remaining PureTech Health position as of Q2 2024 after selling out during the quarter.
  • AWM Investment Company sold 6,900 PureTech Health shares in Q2 2024, an estimated $197K.
  • AWM Investment Company first reported a position in PureTech Health in Q4 2020 and held it in 13 quarters.
  • AWM Investment Company's PureTech Health position peaked at $6.42M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held PureTech Health as of Q2 2024.

Based on AWM Investment Company's 13F filing for Q2 2024, filed 14 Aug 2024.